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Abstract.  Collagen IV is a major component of ver- 
tebrate basal laminae (BLs).  Studies in humans have 
revealed a family of genes encoding or-or6  collagen IV 
chains and implicated ot3-ot6 in disease processes 
(Goodpasture and Alport syndromes and diffuse 
leiomyomatosis). To extend studies of these compo- 
nents to an experimentally accessible animal,  we 
cloned cDNAs encoding partial collagen t~3, u4, and 
ot5(iv) chains from the mouse. Ribonuclease protec- 
tion assays showed that all three genes were expressed 
at highest levels in kidney and lung;  ot5(iv) was also 
expressed at high levels in heart.  We then made anti- 
bodies specific for each collagen IV chain.  Immuno- 
histochemical studies of several tissues revealed many 
combinations of collagen IV chains;  however, t~3 and 
a4 (IV) were always coexpressed, and only appeared 
in BLs that were ot5(iv) positive. The ot3-ol5(iv) 
chains were frequently but not exclusively associated 
with the S (/32) chain of laminin,  as were the or, 2 
(IV) collagen chains with laminin B1  (/~1). An analysis 
of developing rat kidney BLs showed that newly 
formed (S-shaped) nephrons harbored collagen od and 
t~2(iv) and laminin B1; maturing  (capillary loop stage) 
BLs contained collagen cd-ot5(iv) and laminin B1 and 
S-laminin;  and mature glomerular BLs contained 
mainly collagen ot3-ot5(iv) and S-laminin.  Thus,  col- 
lagen otl and ot2(IV)  and laminin B1 appear to be fetal 
components of the glomerular BL, and there is a de- 
velopmental switch to collagen ot3-ot5(iv) and 
S-laminin expression. 
M 
AN Y cells in both vertebrates and invertebrates bear 
a  thin,  insoluble  layer  of  extracellular  matrix 
called  a  basement  membrane  or  basal  lamina 
(BL) ~. The major components of most BLs are two multi- 
meric glycoproteins,  collagen  IV and laminin  (reviewed in 
Rohrbach and Timpl,  1993). Each of these components was 
initially  isolated from tumor tissues as single trimeric spe- 
cies:  (od)2(t~2)l for collagen  IV,  and  A-B1-B2 (also  called 
al-/~l-~/1; Burgeson et al., 1994) for laminin.  Recently, how- 
ever, diversity has been revealed in the subunits  that make 
up these trimers,  with the discovery of the ct3, or4, ct5, and 
t~6(IV) collagen  chains  (reviewed  in Hudson et al.,  1993) 
and the S, M, K, and B2t (also called ~2, t~2, c~3, and 3'2) 
laminin subunits (Burgeson et al., 1994). Moreover, BLs are 
now know to vary in the collagen IV and laminin  isoforms 
they contain (Kleppel  et al.,  1989a,  b; Sanes et al.,  1990; 
Engvall et al., 1990). Thus, all BLs appear to contain some 
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collagen IV and some laminin,  but in different isoform com- 
binations,  suggesting  that  the functional  diversity  of BLs 
arises in part from the particular collagen  IV and laminin 
isoforms they contain. 
Laminin  subunit  diversity  was first demonstrated by the 
discoveries of S-laminin,  a  homologue of the B1  subunit 
(Hunter et al., 1989b), and merosin M, a homologue of the 
A subunit (Ehrig et al., 1990). More recently, K-laminin/ni- 
cein/kalinin/epiligrin  laminin variants have been identified in 
subsets of epithelial BLs (Marinkovich et al., 1992; Kallunki 
et al.,  1992).  The availability  of numerous immunological 
and nucleic acid reagents is rapidly leading to an understand- 
ing of how these individual  laminin  subunits can be assem- 
bled. In tissues and in vitro,  the B2 subunit associates  with 
either the A or M  heavy  subunit  plus either  the B1  or S 
subunit,  producing  a  heterogeneous  family  of  laminin 
trimers (Engvall et al., 1990; Green et al., 1992). At the cel- 
lular  level,  immunohistochemical  studies  have shown that 
most BLs contain either A or M, either B1 or S, and B2. For 
example, renal glomerular basement membrane (GBM) con- 
tains  A, S, and B2, whereas extrasynaptic  muscle BL con- 
tains  M, B1, and B2 (Sanes et al.,  1990). 
For the collagens IV, in contrast,  details of chain assembly 
have  been  difficult  to  determine  because  the  ot3-a6(IV) 
chains have been studied primarily in the context of diseased 
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the  antigen  in  Goodpasture  syndrome,  an  autoimmune 
nephritis which targets the GBM in kidney and the alveolar 
BL in lung (Butkowski  et al., 1987; Sans et al., 1988).  At- 
tempts to purify tx30V) resulted in the discovery of  the colla- 
gen ~x4(IV) chain, which appears to be associated with it 
(Gunwar et al., 1990; Johansson et al., 1992). This work led 
to the hypothesis that either the collagen ix3 or a4(IV) chain 
was mutated in X-linked Alport syndrome, a hereditary glo- 
merulonephritis known to involve defects in glomerular col- 
lagens. In fact, analysis of the mutant allele revealed that it 
encoded yet another chain, ct5(IV) (Hostikka et al.,  1990; 
Barker et al., 1990; Tryggvason et al., 1993). Most recently, 
an tx6(IV) gene was identified next to the tx5(IV) gene and 
shown to be mutated in several X-linked cases of Alport syn- 
drome in which mutations in ct5(IV) could not be detected 
(Zhou et al., 1993; Oohashi et al., 1994). In addition, dele- 
tions that removed parts of both a5 and tx6(IV) were found 
when  Alport  syndrome  was  accompanied  by  diffuse 
leiomyomatosis, a benign proliferation of smooth muscle. 
The juxtaposed or5 and ot60V) genes are arranged in a head- 
to-head orientation on the X chromosome, as are the coregu- 
lated  txl  and Ot2(IV) genes  on  human  chromosome  13 
(Poschl et al., 1988). The o13 and tx4(IV) genes both map to 
human chromosome 2q35-37 and may be similarly arranged 
(Morrison et al., 1991; Turner et al., 1992; Mariyama et al., 
1992b;  Kamagata et al.,  1992). 
Immunohistochemical studies have shown that the  ot3- 
ot5(IV) collagen chains have a restricted distribution in hu- 
man tissues. For example, they are highly enriched in the 
GBM  (consistent with  the  Goodpasture and Alport  syn- 
drome phenotypes) and are also found in a subset of tubu- 
lar basement membranes (TBMs)  (Kleppel et al.,  1989; 
Hostikka et al.,  1990;  Sanes et al.,  1990;  Kleppel et al., 
1992; Hudson et al., 1992).  (No studies on the distribution 
of ot6(IV) have yet been reported.) On the other hand, the 
cd and ix2 chains of collagen IV are abundant in all TBMs 
and in the glomerular mesangial matrix, but are scarce in 
GBM (Kleppel et al., 1989; Kashtan and Kim, 1992; Sanes 
et al., 1990; Kleppel et al., 1992). In human muscle, the ot3 
and ot4(IV)  collagen chains are restricted to the synaptic 
basal lamina at the neuromuscular  junction, while the txl and 
c~2(IV) chains  are  found extrasynaptically (Sanes  et  al., 
1990).  Interestingly, in both renal glomerular and muscle 
synaptic BLs the substitution of collagen oe3-a5(IV)  chains 
for od and tx20V) is accompanied by a substitution of the S 
subunit of laminin for the B1 subunit. 
Taken together, these results raise several questions con- 
cerning BL structure and function: Are there any general 
rules governing the patterns of collagen IV subunit expres- 
sion in BLs? Is there a special association between collagen 
od-o~2(iv) and laminin B1, or between collagen o~3-o~5(IV) 
and S-laminin? Do collagens tx3-cz5(IV) have special roles 
in the GBM or in synaptic BL? Are particular BL isoforms 
(such as the linked pairs of collagen genes) coregulated dur- 
ing development? Here, to begin to address these questions, 
we have cloned cDNAs encoding partial collagen ot3-ot5(IV) 
chains from the mouse, prepared recombinant proteins from 
the cDNAs, and generated antibodies to the proteins. With 
these  reagents,  we performed RNase protection and im- 
munohistochemical studies to analyze the expression pat- 
terns of the collagen IV chains in rodents. Of particular in- 
terest is the finding that the complement of collagen IV and 
laminin chains in the GBM changes systematically as devel- 
opment proceeds. 
Materials and Methods 
Polymerase Chain Reaction 
The PCR  was used to synthesize chain-specific collagen IV probes for 
screening mouse eDNA libraries. For ct3 and c~4(IV) collagen, bovine kid- 
ney poly A + RNA (Clontech, Palo Alto, CA) was reverse transcribed and 
amplified using the GeneAmp RNA PCR Kit (Perkin-Elmer Cetus, Nor- 
walk, CT) with primers based on the published bovine sequences (Morrison 
et ai.,  1991; Mariyama et al.,  1992a).  Primers were: c~3(IV) sense, 5AA 
CCI"GGAGACACTGGACCACCTGC  3';  ct3(IV)  antisense,  5'GTGCTT- 
GCCCAGCACCCTCCGAAC  3';  ot4(IV)  sense,  5'CCTGGATACCTCA- 
GTGGCTTCCTCC  3'; and t~4(IV) antisense, 5'CAGGAACGGTGCGGC- 
TCTGAAATCC  3'. Thermal cycler conditions were: 95°C, I rain; 62°C, 1.5 
rain; 72°C, 2 rain (+ 2 s/cycle), 33 cycles. PCR products were not visible 
by agarose gel electrophoresis after 33  cycles, so 5% of the sample was 
reamplified for 17 cycles, after which products of the expected length were 
detected. For collagen tx5(IV),  we used adult mouse lung total RNA for 
reverse transcript (RT)-PCR with degenerate primers based on the pub- 
lished human sequence (Hostikka et al.,  1990).  The primers were: sense, 
5AA(AG)GGNCA(AG)AG(CT)AT(ACT)CA(AG)CC 3'; antisense, 5'CTA- 
TC(GT)(CT)TTCAT(AG)CANAC(CT)TG(AG)CA 3'. Thermal cycler con- 
ditions were three cycles of 95°C,  1 rain; 51°C,  2.5 rain; 72°C, 2.5 rain, 
followed by 31  cycles of 950C,  1 rain;  55°C, 2.25  rain;  720C,  2.5 rain 
(+1 s/cycle). PCR products were ligated into the pCR II vector using a TA 
Cloning Kit (Invitrogen Corp., San Diego, CA) and analyzed by restriction 
enzyme digestion or sequencing. 
cDNA Library Screening 
The collagen IV fragments were liberated from the pCR II vector by diges- 
tion with EcoRI and isolated by agarose gel electrophoresis. The fragments 
were  32p-dCTP  labeled  with  a  Random  Primed  DNA  Labeling  Kit 
(Boehringer Mannheim Bit)chemicals, Indianapolis, IN). The bovine t~3 
and ¢x4(IV) collagen fragments were used to screen a hgtll mouse kidney 
eDNA library (Clontech) at low stringency. Hybridization conditions were: 
30% formamide, 900 mM NaCl, 90 mM sodium citrate, 50 mM NaPO, 
(pH =  6.5), 0.25 % nonfat dry milk, at 42°C overnight. The mouse collagen 
ct5(IV)  fragment was used to screen a hgtll mouse muscle eDNA library 
(prepared and provided by Mafia J. Donoghue in our laboratory) as above, 
except in 50 % formamide. The inserts of hybridizing phage were subcloned 
into Blue,  script (BS) II SK+  (Stratagene Cloning Systems, La Jolla, CA) 
and sequenced with a Sequenase 2.0 Sequencing Kit (United States Bio- 
chemical Corp., Cleveland, OH). 
Probes  for RNase Protections 
The collagen cd(IV) riboprobe was derived from the plasmid pCIV-l-C87, 
a  eDNA clone from an  Engelbreth-Holm-Swarm library  (Wood et al., 
1988;  obtained from the American Type Culture Collection, Rockville, 
MD). Its 676-bp StyI fragment was blunted, subcloned into the EcoRV site 
of BS II SK+, cut with BstElI, and transcribed with T7 RNA Polymerase 
to synthesize a 279-nucleodde (nt) probe that produced a 224-nt protected 
band. To synthesize the a3(IV) collagen riboprobe, the 5' EcoRI fragment 
(nt 1-552) in BS H SK+ was cut with StyI (nt 187) and transcribed with 
T7 RNA Polymerase to make a 424-nt probe which produced a 365-nt pro- 
tected band. The tx4(IV) collagen probe, also in BS II SK+, was cut with 
StyI (nt 694) and transcribed with T7 to make a 311-nt probe that was pro- 
tected to the EcoRI site (nt 946) to produce a 252 nt band. For the collagen 
~x5(IV) probe, the original RT-PCR product, cloned into the pCR II vector, 
was used. That plasmid was cut with AccI (nt 12 of the sense PCR primer) 
and transcribed with SP6 RNA Polymerase to produce a 461-nt probe and 
an ,'v381-nt protected band. 
RNA Isolation and Analysis 
RNA was prepared from mouse tissues by acid guanidinium phenol/chloro- 
form extraction (Chomczynski and Sacchi, 1987).  Tissues were disrupted 
in the guanidinium solution with a Polytron. For RNase protection assays, 
7/~g total RNA were hybridized with 1-5  x  109 probe molecules. Single- 
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ical Corp.) and 0.4 ng/ml RNaseA (Sigma Chemical Co., St. Louis, MO). 
For details, see Miner and Wold (1991). 
Production of Fusion Proteins and Antisera 
To produce collagen c~3-ct5(IV) proteins, fragments of their cDNAs coding 
for noncollaganous domain 1 (NC1) segments were cloned in frame into the 
proper pET-3 vector (Rosenberg et al.,  1987), all of which contain a com- 
mon short leader sequence. The a3(IV) collagen fusion protein contained 
the final 184 amino acids of c~3(IV)  collagen, the t~4(IV) collagen fusion 
protein contained its final 185 amino acids, and the et5(1V) fusion protein 
contained amino acids  120-248 (see Fig.  1).  The pET-3 expression con- 
strncts were transformed into the BL21(DE3) host strain (Novagen, Inc., 
Madison, WI) and then grown and induced for protein expression according 
to the manufacturer's instructions. Induced bacteria from a 50 rnl culture 
were pelleted, solubilized in sodium dodecyl sulfate loading buffer contain- 
ing dithiothreitol, boiled for 5 rain, and electrophoresed through a prepara- 
tive 10% SDS-polyacrylamide gel (Sambrook et al.,  1989). Proteins were 
visualized in the gel with 0.05 % Coomassie brilliant blue in water (Harlow 
and Lane,  1988) and excised with a razor blade. Gel slices were shipped 
to Cocalico Biologicals, Inc. (Reamstown, PA), where they were used to 
immunize rabbits. A second collagen ct4(iv) fusion protein, containing its 
final 151 amino acids, was used on Western blots (see Fig. 4) but not for 
immunization. 
Antibodies and Immunohistochemistry 
After initial characterization, one antiserum each to collagen c~3, ct4, and 
ct5(IV) was used for subsequent studies. The ct3 and ot4(IV) antisera ini- 
tially recognized all three fusion proteins on Western blots, but subsequent 
experiments suggested that this was mainly due to reaction with the com- 
mon  ll-amino acid leader sequence.  Thus,  much of the cross-reactivity 
could be abolished by incubating diluted antisera with inclusion bodies con- 
taining the pET-3 leader sequence fused to a portion of S-laminin (pET-36; 
Hunter et al.,  1989a),  which is unrelated to collagen IV.  Most of the re- 
maining cross-reactivity was removed by adsorption with inclusion bodies 
containing the noncognate collagen IV fusion proteins, followed by can- 
trifugation. 
Goat  antiserum to  human  collagen  cd,  c~2(IV)  was  purchased  from 
Southern Biotechnology Associates, Inc. (Birmingham, AL). This antise- 
rum reacted with mouse, rat, and human proteins. The collagen cd, ct2(IV) 
monoclonal M3F7 (Foellmer et al., 1983), which reacts with rat and human 
proteins,  was purchased  from ICN  Immunochemicals (Lisle, IL).  Poly- 
clonal (GPS) and monoclonal (C4) antibodies to S-laminin and monoclonal 
antibodies to laminin 131 ((221) and 132 (D18) have been described previously 
(Sanes et al., 1990). Rabbit anti-human c~5(IV) collagen peptide antiserum 
was a kind gift of M.  Kleppel (University of Minnesota Medical School, 
Minneapolis, MN). 
Mouse and rat tissues were frozen in isopentane and sectioned at 4-8 pm 
on a cryostat. Human muscle biopsy material was provided by Kenneth Kai- 
ser and Michael Brooke, then of the Department of Neurology, Washington 
University Medical Center (St. Louis, MO).  In experiments involving the 
rabbit collagen IV antibodies, frozen sections were fixed in 100% ethanol 
for 5 rain at -20°C, rinsed in PBS, and treated with 6 M urea-O.1 M gly- 
cine, pH 3.5, for 1 h at 4°C, before antibodies were applied. The acid-urea 
treatment effectively exposed hidden collagen IV epitopes (Yoshioka et al., 
1985), but it also greatly increased background in rodent (but not human) 
tissues. This background was reduced but not eliminated by applying anti- 
bodies in PBS containing 5-10%  nonfat dry milk.  Fluorescein- and rho- 
damine-conjugated secondary antibodies to rabbit, goat, mouse, and guinea 
pig were obtained from Boehringer Mannfieim Biochemicals, Sigma Chem- 
ical Co., or Cappel/Organon Teknika (Durham, NC), and were also diluted 
in milk and applied for  1-2 h.  In cases where muscle sections were not 
treated with urea-glycine, rhodamine-c~-bungarotoxin was added with the 
second antibody to label neuromuscular junctions. 
Results 
Cloning and Analysis of  Mouse Collagen IV cDNAs 
We  used  the  published  bovine  ot3(IV)  (Morrison  et  al., 
1991),  bovine c~4(IV) (Mariyama  et al., 1992a), and human 
ot5(IV)  (Hostikka  et al.,  1990)  collagen chain eDNA  se- 
quences  to  clone  the  corresponding  mouse  cDNAs  (see 
Materials and Methods). A single 2.2-kb or3 clone, four a4 
clones spanning 2.4 kb, and two or5 clones spanning 2.4 kb 
were isolated. Partial eDNA and deduced amino acid se- 
quences of mouse collagen t~3-u5(IV)  are shown in Fig.  1. 
Mouse, human, and bovine NC1 amino acid sequences are 
compared in Fig. 2 (a-c), and Table I indicates that each hu- 
man protein has a clear mouse ortholog. Fig. 2 d aligns the 
five  cloned  mouse  collagen  IV  noncollagenous  domain 
amino acid sequences, to show that all five sequences are 
highly related. Analysis of these sequences (Table II) indi- 
cates that the al, o~3, and or5 chains comprise one subgroup, 
while o~2 and o~4 comprise a second subgroup. 
Collagen IV RNA Expression 
To survey the tissue distribution of the collagen IV chains, 
we performed RNase protection assays of collagens al and 
t~3-a50V) expression using a panel of mouse tissue RNAs. 
The antisense RNA probes were synthesized so that the u3- 
o~50V)-protected fragments had identical specific activities 
and thus could be compared directly. The od(IV)-protected 
fragment was prepared at one-fourth of this specific activity, 
because we expected od0V) RNA to be more abundant than 
a3-ot5(IV). 
In both neonates (Fig. 3 a) and adults (Fig. 3 b), high levels 
of collagen or(IV) RNA were detected in all tissues rich in 
BLs (heart, kidney, lung, muscle, and skin) whereas tissues 
with fewer BLs (brain and liver) expressed much less colla- 
gen cd(IV) RNA. In contrast, collagen c~3 and a4(IV) RNA 
were relatively abundant in only two of the tissues we tested, 
kidney and lung, while extremely low levels were detected 
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Figure 1. Nucleotide and deduced amino acid sequences of collagen 
c~3(IV) (a), tx4(IV) (b), and c~50V) (c) cDNAs.  Arrows denote the 
start of the COOH-terminal noncollagenous domains, and asterisks 
indicate points of fusion to an expression vector leader peptide for 
production of antisera. These sequences are available from EMBL/ 
GenBank/DDBJ  under  accession  numbers  Z35166,  Z35167,  and 
Z35168. 
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Figure 2. (a-c) Comparison of the mouse collagen ot3-ot5(IV) NC1 
domain amino acid sequences with the known homologous human 
and bovine sequences. A dash indicates identity with the human se- 
quence. (d) Alignment of amino acid sequences of the five known 
mouse collagen IV NC1 domains. Residues that are identical in all 
five NCI domains are boxed. A dash indicates the absence of an 
amino acid at that position relative to one or more of the other pro- 
teins. 
in heart, muscle, and skin. The expression pattern of e5(IV) 
collagen is more similar to that of el(IV) than to that of e 3 
and e4(IV),  most notably in neonates.  Absolute levels of 
e5(IV) RNA are, however, low, i.e., more similar to a3 and 
e4(IV) than to el(IV). Except for adult heart, where e3(IV) 
is absent but e4(IV) is just above the level of detection, there 
is great similarity between e3(IV) and a4(IV) collagen RNA 
Table I. Percentage Amino Acid Sequence Identity between 
Mouse and Human Collagen IV Chain NC1 Domains 
mus al  mus ~t2  mus u3  mus a4  mus c,5 
hum al  97  63  71  59  83 
hum u2  63  99  57  73  62 
hum ~3  68  56  91  53  69 
hum~4  58  69  53  90  58 
hum~5  83  62  72  56  96 
Values of ;*90%  are in bold. 
Table II. Percentage Amino Acid Sequence Identity among 
Mouse Collagen IV Chain NC1 Domains 
al  c~2  a3  c~4  a5 
a I  100  63  70  59  82 
a2  100  57  71  63 
c~3  100  55  71 
a4  100  59 
~5  100 
Values of I>70% are in bold. 
expression,  consistent  with  the  notion  that they  could  be 
coregulated. 
Collagen IV Protein Expression 
Characterization  of A,tisera. Based on these RNA analy- 
ses, we wanted to determine the cellular distribution of the 
collagen IV chains in a subset of BL-rich tissues. However, 
the collagen IV antibodies that had been useful for studies 
in human tissues (Sanes et al.,  1990) did not work well for 
us on rodent tissues. We therefore used a bacterial expression 
system to produce recombinant proteins containing portions 
of the mouse collagen e3-e5(IV) NC1 domains fused to an 
11-amino acid leader. The fusion proteins were purified by 
gel electrophoresis and used as immunogens to produce an- 
tisera in rabbits. Western blot analyses showed that none of 
the antisera recognized purified mouse el or a2(IV) colla- 
gen (data not shown). The e3 and o~4(IV) antisera showed 
cross-reactivity with all three fusion proteins, but >95 % of 
this cross-reactivity was removed by adsorption to the proper 
mixture of insoluble fusion proteins (Fig. 4 a). As an initial 
test for the ability of these antibodies to recognize collagen 
IV in tissue sections, we used them, along with previously 
characterized antibodies to collagen el, 2(IV), to stain hu- 
man kidney,  in which  the distribution  of these chains has 
been previously documented (see Introduction). Staining re- 
quired pretreatment of sections with urea/glycine, which is 
common for antibodies directed against components of BLs 
(Yoshioka et al.,  1985).  Consistent with previous findings, 
anti-collagen el, 2(IV) recognized the glomerular mesan- 
gium and all TBMs but not GBM, while anti-e3,  e4, and 
e5(IV) all recognized the GBM and a subset of TBMs (Fig. 
4, b-e). Based on these immunoblotting and immunofluores- 
cence results, we conclude that our new antibodies exhibit 
appropriate reactivities. 
Kidney. In adult mouse (Fig. 5, a-d) and rat (Fig. 5, e-h) 
kidneys,  anti-collagen  el,  e2(IV)  antibodies  stained  all 
TBMs, the BLs of blood vessels, and the glomerular mesan- 
gial  matrix  intensely,  but  stained  the  GBM  poorly.  The 
anti-collagen e3, e4, and e5(IV) rabbit antisera stained the 
The Journal of Cell Biology, Volume 127,  1994  882 Figure 3.  Ribonuclease protection analyses  of collagen IV chain 
gene expression  in tissues of newborn (a) and adult (b) mice. 7 #g 
of total RNA were used to protect each probe, and yeast type HI 
RNA was used as a negative control. The c~3-c~5(IV)  protected frag- 
ments had the same specific activity,  so their signal intensities  are 
proportional to their relative abundance; the cd(IV) probe had one- 
fourth of this  specific  activity.  Note that the lower band of the 
doublets observed for ~x4 in b is background, as it also appears in 
the yeast lane. 
GBMs intensely and also stained a great majority of the cor- 
tical and inner medullary TBMs, but the mesangium, blood 
vessel BLs, and a large subset of TBMs in the outer medulla 
were not stained.  We could detect no significant differences 
in localization among the o~3-cx5(IV) collagen chains. 
The overall pattern of collagen IV chain expression was 
very similar in adult mouse and rat kidneys, as well as in ro- 
dent  and human glomeruli.  However,  we consistently  ob- 
served  a  significant difference between  human and rodent 
tubules.  In  human,  TBMs  of  a  small  subset  of tubules 
identifiable  as  distal  tubules  (Kleppel  et  al.,  1989)  are 
stained with the collagen ot3-ot5(IV) antisera (Fig. 4, c-e). 
In the rodent cortex,  in contrast,  both proximal and distal 
TBMs were stained (Fig.  5 fand data not shown; note that 
Figure 4. (a) Western analysis of  rabbit anti-collagen c~3-c~5(IV)  an- 
tisera reactivity with collagen IV fusion proteins.  Each lane con- 
tained all three bacterially produced fusion proteins,  as indicated. 
Before being applied  to blots,  the ot3(IV) antiserum was adsorbed 
with inclusion bodies containing S-laminin  and collagen ~x4 and 
c~5(IV) fusion proteins; the a4(IV) antiserum was adsorbed with 
inclusion  bodies  containing  S-laminin  fusion  protein;  and  the 
c~5(IV) antiserum was adsorbed with inclusion bodies containing 
collagen or3 and ~x4(IV) fusion proteins.  The S-laminin  fusion pro- 
tein ~pET-36) contains the same pET leader peptide as the collagen 
IV fusion proteins.  (b-e) Immunohistochemical analysis  of colla- 
gen IV chains in human kidney, b shows staining with mouse mAb 
M3FT, which is specific  for collagen ~xl, 2(IV); staining  is most 
prominent in tubular basement membranes (TBMs) and in glomeru- 
lar mesangium, c-e show staining with adsorbed rabbit anti-colla- 
gen a3-~x50V),  respectively. Staining is intense in GBM and a sub- 
set of TBMs but is absent from other TBMs and the mesangium. 
G, glomerulus;  T, tubule.  Bar,  50 #m. 
Miner and Sanes Mouse Collagen IV Chains  883 Figure  5.  Distribution of collagen IV chains in rodent kidney BLs. Sections were stained with goat anti-~l, 2flV) (a), mouse anti-~l, 
2(IV) (e and g), anti-~30V) (b), anti-~4(IV) (c,f, and h), or anti-c~50V) (d). a-d are low power micrographs of mouse kidney showing 
glomeruli and tubules, e-h are higher power micrographs of rat kidney, showing a glomerulus with surrounding tubules (e and f) and 
a medullary vascular bundle with surrounding tubules (g and h). e, f  and g, h show the same sections, doubly labeled. The collagen ¢1, 
20V) antibody stains glomerular mesangium and most TBMs (a and e). ot3-a5(IV) antisera stain all GBMs but only some TBMs and 
no mesangium (b-d,f, and h). At the ~ortico-medullary  junction (a-d), many collagen cd, 20V)-l~itive TBMs do not stain with collagen 
c~3-~5(IV) antisera, while in the outer cortex (e and  f) ~3-~5(IV)-negative TBMs are rare; one "IBM not stained by anti-<x4(IV) is indicated 
by an arrowhead inf. In the medulla, anti-el, 2(IV) stains bundles of blood vessels as well as the surrounding tubules (g); these blood 
vessels are not stained by the collagen c~3-~5(IV) antisera (c~4 shown in h).  G, glomerulus; T, tubule;  V, vascular bundle. Bars: (a-d) 
100 t~m; (e-h) 50 ttm. 
The Journal of Cell Biology,  Volume 127, 1994  884 Figure 6. Distribution of  collagen IV chains in P6 rat skin. Sections 
were doubly labeled with mouse anti-collagen txl, 2(IV) (a and c) 
plus either rabbit anti-collagen tx4(IV) (b) or anti-collagen c~5(IV) 
(d). The collagen od, 2(IV) antibody stains the epidermal BL (ar- 
rowheads) and a variety of structures in the dermis. The collagen 
tx4(IV) antiserum stains few if  any BLs in the skin (b). The collagen 
tx5(IV) antiserum stains the epidermal BL well, but only some of 
the dermal BLs (d). Bar, 50/~m. 
Fig. 5, a-d shows the corticomedullary  junction, where a3- 
a5[IV]-negafive tubules are especially prominent). 
Skin.  To  determine  if collagens  a3-a5(IV)  are  codis- 
tributed generally, we used these antibodies to stain sections 
from skin, in which RNase protection had shown higher lev- 
els of a5(IV) than of a 3 and c~40V) RNAs (Fig. 3). In both 
rat (Fig. 6) and mouse (data not shown) the epidermal base- 
ment membrane was brightly positive for al, a2, and aS(IV) 
collagen chains (Fig.  6, a,  c, and d), but collagen a3 and 
a4(IV)  were  nearly undetectable  (Fig.  6  b  and  data  not 
shown). Thus, the collagen a3, a4 and c~5(IV) chains are not 
always colocalized. 
Muscle. The BL at the neuromuscular  junction is morpho- 
logically and  functionally distinct  from the  extrasynaptic 
BL. Much of our interest in the collagen IV chains stems 
from our finding in human muscle that a3 and a4(IV) chains 
are restricted to the neuromuscular  junction, whereas cd 'and 
a2(IV) are less abundant synaptically than extrasynaptically 
(Sanes et al.,  1990). The data presented in Fig. 7, a  and b, 
extend these results by showing that collagen a5(IV) is also 
concentrated in human muscle synaptic BL, as determined 
by using both our rabbit antiserum (Fig. 7 a) and a human- 
specific  peptide  antiserum  (Fig,  7  b).  Synapses  were 
identified by their staining with rhodamine-labeled a-bUn- 
garotoxin or an antibody to S-laminin, a laminin BI homo- 
logue expressed at neuromuscular junctions (Hunter et al., 
1989b). In the rat (Fig. 7, c-f) and mouse (data not shown), 
collagen cd and a2(IV) were expressed in all BLs except for 
Figure 7. Distribution of  coUagen  IV chains in human (a and b) and 
rat (c-f) muscle BLs. (a) Rabbit anti-mouse collagen orS(IV). (b) 
Rabbit anti-human c¢5(IV)  collagen peptide. (c) Goat anti-collagen 
od, 2(IV). (d) Rabbit anti-collagen ot3(IV). (e) Rabbit anti-colla- 
gen ot4(IV). (f) Rabbit anti-collagen a5(IV).  All  sections were 
doubly labeled to identify synaptic sites, using either mouse anti- 
S-laminln (a', and d'-f')  or rhodamine-c~-bungarotoxin  (b' and 
c'). Arrow in c notes the ~-bungarotoxin-positive synaptic BL that 
is collagen al, 20V) negative. In rat, collagen c~5(IV)  appears more 
abundant at synapses than a3(IV) and a4(IV) collagen chains, but 
it also is found extrasynaptically at lower levels in some muscle 
fibers (f). Bar, 20 ~m. 
Miner and Sanes Mouse Collagen IV Chains  885 Figure 8.  Distribution of collagen IV chains and laminin subunits in rat kidney.  In a  and b  (doubly labeled),  S-laminin (a) and collagen 
c~4(IV) (b) are codistributed in the (iBM.  However, S-laminin is also seen in the glomerular mesangium and in blood vessels but not in 
TBM,  while tx4(IV) collagen is additionally  seen in most TBMs but not in mesangium or blood vessels. In c  and d  (nearby sections), 
laminin B1  (c) and collagen t~l,  20V)  (d) are codistributed in TBMs and,  to a  lesser extent,  in mesangium. G, glomerulus; T, tubule; 
V, blood vessel. Bar,  50 #m. 
synaptic BL, while ct3 and a4(IV) were detectable only in 
the synaptic BL. ot5(IV)  collagen was also concentrated at 
synapses, but low levels of  this chain were also detectable ex- 
trasynaptically in many muscle fibers in both rat and mouse. 
Collagen IV and Laminin Subunit Associations 
Results presented previously and above show that glomeru- 
lar and muscle synaptic BLs in human, mouse, and rat ex- 
press the S-laminin and o~3-o~5(IV)  collagen chains. We per- 
formed a  series of double-labeling studies to determine if 
there is a general association of S-laminin with collagen o~3- 
c~5(IV), and/or of laminin B1 with collagen od and ot2(IV). 
Results for rat kidney are shown in Fig. 8, and data from all 
tissues  examined are  summarized in Table HI.  In kidney, 
S-laminin was associated with collagen ot3-o~5(IV) chains in 
GBM but with collagen cd, 2(IV) chains in blood vessels. 
Similarly, the collagen ~3-c~5(IV) chains could associate ei- 
ther with S-laminin (in GBM) or with laminin BI (in TBM). 
Other combinations were observed elsewhere (Table III). 
Thus, there is no exclusive association of collagen od, 2(IV) 
with laminin B1, or of collagen c~3-ol5(IV) with S-laminin. 
Collagen IV and Laminin Subunit Expression 
during Development 
Collagen ,3-ot50V) chains have so far been studied mostly 
in adults because, as noted in the Introduction, most studies 
have been restricted to human material. The availability of 
probes  for rodent mRNA  and protein facilitates study of 
these chains during development. Here, we focus on kidney, 
because it is rich in all of the collagen IV chains, as well as 
both S and B1 subunits of laminin. Moreover, kidney devel- 
opment proceeds postnatally in a graded fashion such that 
a single kidney section from the first postnatal week contains 
glomeruli and tubules at all stages of development, with the 
Table III. Occurrence of  Collagen IV Chains and l_zvninin 
Subunits in Various  Adult Rodent BLs 
Collagen IV  Laminin 
al/2  or3  t~4  t~5  BI  S  B2 
Muscle 
Synaptic  +  +  +  +  - 
Extrasynaptic  +  -  -  +  + 
Arterial  +  .... 
Intramuscular nerve 
Endoneurial  +  -  -  -  + 
Perineurial  +  .... 
Kidney 
Glomerular  +  +  +  +  - 
Tubular  +  +&-  +&-  +&-  + 
Mesangial  +  -  -  -  + 
Arterial  +  .... 
Skin 
Epidermal  +  -  -  +  + 
Dermal  +  -  -  + & -  + 
Lung 
Alveolar  +  +  +  +  + 
Esophagus 
Epithelial  +  +  +  +  + 
+  + 
--  + 
+  + 
--  + 
+  + 
+  + 
--  + 
+  + 
+  + 
-  + 
-  + 
-  + 
-  + 
+, stained;  -,  unstained;  +, dimly stained;  +&-,  some  +  and others  -. 
Mesangium, though not a BL, is included for comparison. 
The Journal of Cell Biology, Volume  127, 1994  886 most primitive structures found in the outermost part of the 
cortex (Ekblom, 1981; Davies,  1993). 
Glomeruli. As the first step in nephron development, the 
ureteric bud branches into nephrogenic mesenchyme and in- 
duces it to condense into a  sphere and epithelialize. This 
vesicle then undergoes a  defined progression of morpho- 
genetic  changes  that  result  in  its  transformation into  a 
glomerulus. Successive stages are termed comma-shaped, 
S-shaped, capillary loop, immature glomerular, and mature 
glomerular (Sorokin and Ekblom, 1992; Davies, 1993).  As 
noted above, nephrons are added at the cortical surface, and 
all stages of development are encountered successively in a 
cortico medullary traverse. In the newborn rat, GBMs at all 
but the most mature stages contained collagen txl,  2(IV) 
(Fig. 9, aand c). Glomeruli from the capillary loop stage and 
onward also harbored collagen c~3-c¢5(IV) in their BLs, here 
represented by a3fiv) staining (Fig. 9, b and d). In the most 
mature glomeruli, collagen od and ot2(IV) were no longer 
abundantin the GBM but were present at a high level in the 
mesangial matrix (Fig. 9 c). Thus, there is a progression of 
collagen IV. ieffiain expression in  the GBM:  only oil  and 
c~2(iv) are detected initially; then txl-tx5(IV) are all present; 
and finally, a3-o~5(iv) become the predominant chains. 
This' transition raised the question of whether collagen- 
laminin associations changed during development. To exam- 
ine this issue, we stained sections from the same blocks with 
antibodies to the laminin S, B1, and B2 subunits. Interest- 
ingly, the transition in collagens IV is accompanied by an 
isoform transition in laminin Bl-like subunits. Laminin B1, 
like collagen od, 2(IV), was found in all developing GBMs 
(Fig.  9  e), while S-laminin, like the collagen o~3-ot5(IV) 
chains, was first detected at the capillary loop stage (Fig. 9 
f). In fact, we could find no developing glomeruli that con- 
tained S-laminin but not the collagen o~3-a5(IV) chains, and 
the converse was also true. In the most mature glomeruli, 
laminin B1 was no longer found in GBM but was abundant 
in the mesangium (Fig. 9 g), while S-taminin remained in 
the GBM  (Fig.  9  h).  Consistent with its being the most 
widely expressed subunit of the laminin trimer, laminin B2 
was found in both the GBM and the mesangial matrix at all 
stages of glomerular development (Fig. 9, i and j). 
Tubules. The tubular portion of the nephron forms as an 
extension of one end of the S,  shaped structure, which fuses 
to the ureteric bud/collecting duct, elongates, and convo- 
lutes. In neonates, tubules expressed collagen al, 2(IV) and 
laminin B1 and B2 but not collagen ot3-a5(IV) or S-laminin 
(Fig. 9). By P7, restricted groups of TBMs had begun to ac- 
cumulate the a3-tx5(IV) collagen chains (Fig. 9 k and data 
not shown). All tubules continued to express collagen c~l, 
2(IV)  and laminins B1  (and B2;  data not shown),  while 
S-laminin was never detected in TBM (Figs. 5 and 8). Thus, 
both  tubular  and  glomerular  BLs  acquire  collagens  ct3- 
c~5(iv)  late in development, but only in glomeruli is this 
switch accompanied by the loss of cd,2(IV) and laminin B1 
and the acquisition of S-laminin. 
Discussion 
To learn how structural differences among BLs contribute to 
their functional specialization, it is important to ascertain 
the makeup of individual BLs in an experimentally accessi- 
ble mammal, in which genetic and surgical manipulations 
are possible. To this end, we have cloned and characterized 
cDNAs encoding the ct3OV), ot4(IV), and c~5(IV) chains of 
mouse collagen IV. We produced antisera to the respective 
recombinant proteins and then used them along with previ- 
ously characterized antibodies to determine the combina- 
tions of collagen IV chains and laminin subunits found in the 
BLs of several tissues. We thereby extended previous work 
on the molecular heterogeneity of BLs in adult animals, and 
provided new evidence for systematic changes in composi- 
tion of individual BLs during development. 
The Collagen IV Gene Family 
Analysis of the txl-c~5(IV) NCI domain sequences shows that 
the five mouse proteins have unequivocal human orthologs 
and can be divided into two evolutionarily related groups: 
al, ct3, and ct5(IV); and or2 and cz4(iv). Such a relationship 
has previously been noted for the bovine and human collagen 
IV chains (Mariyama et al.,  1992a)  and is consistent with 
the paired,  head-to-head arrangement of od  with c~2(IV) 
(Poschl et al.,  1988),  ct5 with ct6(iv) (Zhou et al.,  1993), 
and probably ct3 with ct4(IV) (Morrison et al., 1991; Turner 
et  al.,  1992;  Mariyama et  al.,  1992b;  Kamagata et  al., 
1992).  This arrangement suggests that a single, ancestral 
collagen IV gene was duplicated and inverted to form a head- 
to-head pair, which was then duplicated twice to yield the 
three present day loci (Hudson et al., 1993).  NC1 domain 
comparisons also show that the od(IV) chain is more similar 
to a5(iv) than to o¢3(IV) (Table I), and comparisons with in- 
vertebrate collagen IV genes indicate that cd(IV) collagen is 
most similar to the presumed ancestral collagen IV chain 
(Quinones et al., 1992).  Taken together, these observations 
suggest the following scheme: an ancestral collagen IV gene, 
today represented by the widely expressed cd(IV),  dupli- 
cated and inverted to produce the otl/tx2(IV) locus. This lo- 
cus then duplicated twice, first to produce the cz3/a4(IV) 
pair and then again to produce the cz5/ot6(IV) locus. 
It has been determined that the paired cd and ot2(IV) genes 
share a  common, bidirectional promoter (Soininen et al., 
1988;  Poschl et al., 1988; Burbelo et al., 1988).  Given the 
likelihood that the two other collagen IV pairs arose by dupli- 
cation of that locus, the ot3/u4(IV) and o~5/ct6(iv) gene pairs 
may be similarly regulated. Indeed, the transcription start 
sites of the collagen ct5 and o~6(IV) genes are separated by 
under 500 bp in both human (Zhou et al., 1993) and mouse 
(J. H. Miner, unpublished), and our RNA expression data 
(Fig. 3)  support the notion of coordinate regulation of ct 3 
and 0¢4(IV). The expression pattern of the oe5(IV) collagen 
gene is similar to that of od(iv), albeit at lower levels, and 
this correlates with the closer evolutionary relationship be- 
tween these genes, presumably including their regulatory 
regions. 
Coordinate and Independent Regulation of Collagen 
IV Chains 
To study the localization of  collagen IV chains in rodent BLs, 
we needed to produce antisera to mouse collagen t~3, or4, 
and a5(IV) fusion proteins, because the antibodies that had 
worked well on human sections (Sanes et al.,  1990)  failed 
to stain mouse or fat sections. However, due to the extensive 
similarity among the members of the collagen IV gene fam- 
ily (Fig. 2 d), we realized that each antiserum might react 
Miner and Sanes Mouse Collagen  IV Chains  887 Figure 9.  Distribution of collagen IV chains and laminin subunits in newborn (a-j) and P7 (k) rat kidney. The more primitive structures 
found in the outer cortex are shown in a, b, e,f, and i, and the more mature inner cortical structures are shown in c, d, g, h, andj. Sections 
were stained with antibodies to collagen al, 2(IV) (a and c), cx3(IV) (b and d),  laminin B1  (e and g), S-laminin (land h), laminin B2 
(i and j), and collagen a40V) (k). a/b,  c/d,  e/f,  and g/h are doubly labeled pairs. The mouse collagen ~1, 20V) mAb stains most BLs, 
including  GBM, in the most primitive, outer cortical nephrons (a), but staining in the more mature, inner  cortical glomeruli is found primar- 
ily in the mesangium (c). b and d are the same sections as a  and c double stained with anti-collagen ~x3(IV). Note that the comma and 
S-shaped structures are unlabeled, but the (3BMs of capillary loop and later stage nephrons show staining. Similar staining is seen with 
The Journal of Cell Biology, Volume 127, 1994  888 with all of  the collagen IV chains. To test for cross-reactivity, 
we performed Western blot analyses, which showed that the 
three  antisera  did  not  recognize purified collagen  ul  or 
ot2(IV). The or3 and t~4(IV) antisera initially reacted with all 
three fusion proteins, but adsorption to the proper mixture 
of insoluble fusion proteins removed nearly all of this cross- 
reactivity (Fig. 4 a). 
The behavior of our antisera in immunohistochemical as- 
says provides additional evidence that they do not cross-react 
with collagen ul or ct2(IV). For example, we found many 
sites of abundant collagen t~l, 2(IV) expression which were 
negative for ct3-ot5(IV)  (Table m);  this would not be ob- 
served if our antisera cross-reacted with the od or o~2(IV) 
chains. Also, the absorbed ct3(IV) and ct4(IV) antisera did 
not stain a5(IV)-positive extrasynaptic muscle or skin (Table 
IH) BLs, indicating that neither recognized o~5(iv). 
We  found that  the  collagen  t~l  and  ct2(IV)  chains  are 
widely distributed  in  many  BLs,  whereas  the  ot3-o~5(lV) 
chains are more restricted in their expression (Table III). In 
the adult, collagen or3 and ot4(IV) chains were consistently 
coexpressed, as shown by immunohistochemical and RNase 
protection assays.  This is consistent with the hypothesis that 
they are coregulated and with the finding that their NC1 do- 
mains associate with each other (Johansson et al.,  1992). 
However, while the collagen c~5(IV) chain accompanied or3 
and a4(IV) in GBM, TBM, and synaptic BL, the epidermal 
BL was strongly positive for collagen o~5(IV) but contained 
little  collagen  a3  or o~4(IV). Taken together,  our results 
document four patterns of  collagen IV expression in adult ro- 
dent BLs:  al-~5(IV)  (e.g.,  in  some TBMs);  ul,  or2,  and 
ct5(IV)  (e.g.,  in epidermal BL);  od  and c~2(IV) (e.g.,  in 
blood vessel and nerve BLs); and ct3-ct5(IV)  (e.g., in GBM 
and synaptic BL). So far we have not found BLs which con- 
tain collagen c~3 and t~4(1V) but not ct5(IV), and we have 
never found o~5(IV) alone. These results are consistent with 
those obtained using human tissues (Kleppel et al.,  1989a; 
Sanes et al., 1990; Hostikka et al., 1990). However, one im- 
portant difference in collagen IV expression between rodents 
and humans is that the majority of TBMs present in a typical 
rodent kidney section are positive for ot3-a5(IV) collagen 
chains (Fig. 5), whereas in human kidney such TBMs are 
rare (Fig. 4, b-d) and have been identified as distal TBMs 
(Kleppel et al.,  1989a, b).  Another notable difference be- 
tween rat and  human  is  revealed by the collagen oe5(IV) 
staining pattern in muscle: while ot5(iv) collagen is concen- 
trated at synapses in both rat and human muscle, it is also 
found extrasynaptically in some rat muscle fiber BLs, though 
at much lower levels (Fig. 7 and data not shown). 
Relationship of Collagen IV and Laminin B Chains 
Like the  collagen cd  and  ct2(IV)  chains,  the  laminin  B1 
subunit (/31) is widely expressed; like the oe3-a5(IV) chains, 
S-laminin (/~2) is restricted to a small subset of BLs. In some 
cases, the expression patterns of these BL components ex- 
hibit remarkable parallels. For example, S-laminin and col- 
lagen  ot3-oe5(IV)  are  concentrated  at  the  neuromuscular 
junction and in GBM, and laminin B1 and collagen od and 
ot2(IV) are absent or greatly diminished at both sites. Like- 
wise, extrasynaptic muscle BL is rich in laminin B1 and col- 
lagen cd and a2(IV), whereas S-laminin and ot3-ct5(IV) are 
absent or greatly reduced compared with synaptic BL. How- 
ever, these parallel patterns are not obligatory. Collagens c~3- 
oe5(IV) are found without S-laminin in TBMs, and S-laminin 
is found without a3-t~5(IV) in blood vessels. Likewise, col- 
lagen otl and ~t2(IV) are found without laminin B1 in blood 
vessels. We have, however, found no BLs in which laminin 
B1 is unaccompanied by the od and a20V) collagen chains. 
Replacement of  Basal Lamina Components during 
Renal Development 
In the earliest stages of glomerular development (vesicle, 
comma, and S-shaped structures) we found BLs that con- 
tained collagen cd and ot2(IV) and laminin B1. At the capil- 
lary loop stage, we began to detect collagen ot3-o~5(IV) and 
S-laminin  in  the  GBM;  these  appeared  coordinately and 
were colocalized with collagen oil and o~2(IV) and laminin 
B1. This coordinate appearance is noteworthy, because even 
though there is no obligatory association between collagen 
c~3-t~5(IV) and S-laminin, they appear to be coregulated in 
this instance. Finally, as glomeruli matured, we found that 
collagen od and ot2(IV) and laminin B1 became concentrated 
mainly in the mesangium, while the GBM continued to ac- 
cumulate ct3-u5(IV) and S-laminin. Thus, during GBM de- 
velopment, collagens ct3-ct5(IV) replace od and ~2(IV), and 
S-laminin replaces laminin B1. A  laminin B1 to S-laminin 
switch has also been reported in developing nerve (Jaakkola 
et al.,  1993),  and previous studies on fetal human kidney 
provided preliminary evidence for the collagen IV  switch 
that we have documented here (Kleppel and Michael, 1990). 
At least in kidney, this appears to be a  true replacement 
rather  than  the  formation  of a  totally  new  BL because 
double-labeling experiments revealed a colocalization of the 
late-appearing isoforms with their more widely distributed 
counterparts (Fig. 9). However, interspecies grafting experi- 
ments and ultrastructural analyses have shown that the ma- 
ture GBM forms from fusion of separate endothelial and epi- 
thelial BLs (Sariola et al., 1984; Abrahamson, 1985). Thus, 
it is possible that one of these BLs contains collagen ct3- 
t~5(IV) and S-laminin and the other cd, t~2(IV), and laminin 
B1. In any event, since collagen t~l, t~2(IV),  and laminin B1 
are  eliminated  from the  maturing  GBM  (Desjardins  and 
Bendayan, 1991; Abrahamson and St. John, 1992; Fig. 9) as 
t~3-a5(IV) and S-laminin appear, there must be some mech- 
anism to coordinate the transition. 
BL composition also changes in developing TBMs, but in 
a different way. All TBMs at all stages were positive for col- 
lagen od and ~t2(IV) and laminin B1, but we never detected 
S-laminin, and significant amounts of ~ 3-et5(IV) did not ac- 
the or4 and ot5(IV) collagen antisera (data not shown), e and g are stained for laminin B1 and show a pattern virtually identical to collagen 
or, 2(IV). These same sections viewed for S-laminin (f and h) show glomerular staining very similar to collagen t~3(IV), i and j  show 
laminin B2 staining at all stages of nephron development, but in contrast to laminin B1, B2 remains in mature GBM. (k) By P7, many 
TBMs are positive for t~4(IV) (compare P0, b and d). U, ureteric bud; S, comma and S-shaped structures; C, capillary loop BL; G, glomeru- 
lus. Bar, 50 gm. 
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collagen a3-a5(IV) to od and ct2(IV) in TBM that is not syn- 
chronous with their appearance in GBM. 
The replacement of  collagen cd, 2(IV) and laminin B1 with 
collagen c¢3-c¢5(IV) and S-laminin in the developing GBM 
is reminiscent of the embryonic to adult myosin and the fetal 
to adult hemoglobin switches (Whalen et al., 1981; Maniatis 
et al., 1980). However, the collagen IV and laminin switches 
are different in that what are "fetal" isoforms in some tissues 
persist into adulthood in others. This suggests that there are 
distinct mechanisms for spatial and temporal regulation of 
the  individual  BL  components  in  different tissues.  It  is 
noteworthy to mention here that  in  Alport  syndrome,  in 
which one or more of the ot3-ct6(IV) collagen chains are ab- 
sent, there is a marked increase in oil and ot2(IV) chains in 
the GBM (Kashtan and Kim, 1992). This can be viewed as 
a reactivation of the "fetal" isoforms, which may act to slow 
the  onset  of end-stage  renal  disease  in  Alport  patients. 
Moreover, it implies that there is a mechanism for reactivat- 
ing fetal BL components and assembling them into mature 
(though compromised) BLs. 
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